Drugs / Sculptra
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT05963204 | Jul 2023 → Mar 2024 | midface dysplasia | Galderma R&D | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01422538 Comparator | May 2011 → Jun 2012 | — | Ulthera, Inc | Completed | No outcome recorded |
Press releases naming this drug 12 releases
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sculptra | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05963204 ↗ |